
The Role of Aberrant Cytokine Activity in COVID-19 Disease
Presented by: Kenneth Oh, PhD, Collaborations, Applications, and New Technology Senior Global Manager
Kelly King, PhD, Field Application Specialist II
Brad VanderWielen, PhD, Field Application Specialist II
Candice Cox, Global Marketing Manager, Immunoassays
View on demand
Emerging reports from the COVID 19 pandemic include a spectrum of patient symptoms due to the host immune response. In this webinar, Bio-Rad scientists discuss early research and nascent hypotheses about the pathophysiology of SARS CoV 2–induced COVID 19 disease by evaluating cytokine and chemokine profiles, the role of chronic inflammation in comorbidities, and the arc of immune resolution of historical virulent pathogens, such as SARS and MERS.

7 Tips for Purchasing Your Next Cell Sorter

Sorting an Old Problem: Are Cells Stressed by Fluorescence-Activated Cell Sorting?

How to Make a Successful Vaccine
Episode 7: Data Standardization

10 Tips for Setting Up a Successful Cell Sorting Experiment

Expert Coffee Chats: Coffee Chat #4 – Droplet Digital PCR in Cell and Gene Therapy
Presented by: Matthew L. Turner, PhD, Field Application Scientist – ddPCR, NGC and qPCR, Tara Ellison, PhD, Senior Field Application Scientist
Date: June 17, 2020
Time: 9 AM, U.S. Pacific time
- Robust methodology for viral titer using ddPCR
- Precise copy number determination & improved confidence in acceptance criteria
- Enhance your throughput and minimize hands-on time
- Learn how ddPCR is used in other key applications
Episode 6: Genomic Data Disparities

Reference Gene Selection Using PrimePCR Plates and CFX Maestro Software

Biosimilar Purification with Ion Exchange and Mixed-Mode Resins
Presented by: Randy Drevland, PhD, Senior Applications Scientist
View on demand
Dr. Drevland presents a viable alternative workflow for the development of a HUMIRA-like biosimilar using IEX and mixed-mode resins.